UNIVERSITY OF PENNSYLVANIA
Investigating Type I Interferon response and differentiation in FLT3-inhibitor persistent acute myeloid leukemia
Investigating Type I Interferon response and differentiation in FLT3-inhibitor persistent acute myeloid leukemia is a funding opportunity from UNIVERSITY OF PENNSYLVANIA, up to 434969, closing April 30, 2031.
Apr 30, 2031
(1734d left)Overview
PROJECT SUMMARY Acute myeloid leukemia (AML) is a genetically and cellularly heterogenous disease characterized by the expansion of hematopoietic cells across a range of cell states from stem-like cells to differentiated myeloid cells. The most mutated genes in AML are DNMT3A, NPM1 and the receptor tyrosine kinase…